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a b s t r a c t
We present the case report of a 56-year-old man with an unusual manifestation of an
accessory pathway. Failure to detect, or incorrect diagnosis, of this anomaly could have put
the patient at high risk of sudden cardiac death. The accessory pathway described in this
case report was located at the left posteroseptal area and presented initially with a broad
QRS complex tachycardia. Despite being pre-excited atrial ﬁbrillation, it could have been
misinterpreted as ventricular tachycardia. Once the rhythm had changed to sinus, a Q-wave
in the inferior ECG leads became apparent. This ﬁnding could have been misdiagnosed as an
old myocardial infarction and treated as such, including prescription of betablockers which
might, in theory, increase the risk of sudden cardiac death. The treatment of choice for the
patient was radio frequency ablation of the accessory pathway.
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.Introduction
Accessory atrioventricular (AV) pathways represent a pres-
ence of abnormal conductive tissue between atria and
ventricles. They can be clinically completely asymptomatic,
but on the other hand the abnormal accessory AV conductivity
may result in narrow or broad complex tachycardia. In the
latter case the diagnosis may be less obvious and the
electrocardiogram (ECG) can be misinterpreted. We present
the case report of one of these manifestations to stress out the
need for carefully set diagnosis.§ Supported by the programme PRVOUK P37/03.
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reserved.Case description
A 56-year-old man was admitted to the cardiology department
with a 2-day history of exertional shortness of breath,
weakness and fatigue. He also developed central chest
discomfort (pressure) and presented to the accident and
emergency (A&E) department 2 hours later. He denied having
any palpitations or collapse. He was an ex-smoker who
stopped smoking 5 years ago and his past medical history
comprised of arterial hypertension and chronic allergic
alveolitis. His medications included losartan 50 mg/D,(J. Hurychova).
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Fig. 1 – ECG on admission. Irregular broad complex tachycardia, positive concordancy + LAH morphology: pre-excited atrial
fibrillation with rapid ventricular response, shortest pre-excited RR interval 200 ms.
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low fat diet due to hypercholesterolaemia. He had a positive
family history of a premature ischaemic heart disease (his
father died from myocardial infarction at 60). On admission, he
was haemodynamically stable with no signs of heart failure,
BP was 120/70 mmHg and heart sounds were irregular 230
beats per minute with the peripheral pulse deﬁcit. The
pressure chest pain eased off completely with sublingual
nitrate. ECG on admission (Fig. 1) showed irregular broad-
complex tachycardia (BCT) with positive concordancy in
precordial leads, left axis deviation (LAH) and a ventricular
rate of approximately 250 beats/min. The tachycardia was
initially slowed down by i.v. amiodarone 300 mg but, as he
remained tachycardic he was cardioverted to sinus by
synchronized electrical cardioversion. The subsequent ECG
(Fig. 2) showed sinus rhythm with varying QRS width and Q
wave pattern in leads III and aVF. No previous ECG was
available for comparison. Blood results were unremarkable
with no electrolytes abnormalities, normal thyroid function
test and normal creatine kinase (including MB fraction).
Troponin T was slightly elevated. Transthoracic echocardiog-
raphy was carried out and revealed well maintained left
ventricular systolic function with mild multifocal regional wall
motion abnormalities and moderate mitral regurgitation.
What is the diagnosis?
On detail ECG analysis we can see a broad complex tachycardia
which could be misinterpreted as ventricular tachycardia (VT),
but the obvious irregular rhythm indicates that the correctdiagnosis is pre-excitated atrial ﬁbrillation with an antegra-
dely conducting accessory pathway (Fig. 1). Shortest pre-
excited RR interval 200 ms indicates high-risk accessory
pathway (very fast antegrade conduction via accessory
pathway with risk of degeneration to ventricular ﬁbrillation).
The varying QRS width on ECG after electrical cardioversion is
caused by pre-excitation including Q wave pattern in the
inferior leads which is in fact a negative delta wave. Pre-
excitation is more expressed with atrial premature beats
(Fig. 2).
This patient underwent an electrophysiology study which
conﬁrmed the presence of the atrioventricular accessory
pathway in the left posteroseptal region (antegrade conduc-
tion – atrial effective refractory period/ERP/240 ms, accessory
pathway ERP < 260 ms, AV re-entry tachycardia non-induc-
ible). The pathway was successfully ablated (Fig. 3) with no
further ECG evidence of pre-excitation (Fig. 4).
Discussion
Accessory atrioventricular pathways are congenital abnor-
malities involving the presence of abnormal conduction tissue
between the atria and the ventricles which can cause early
depolarisation of the ventricular myocardium: pre-excitation.
The ﬁrst suggestion of the existence of these pathways was
mentioned by Holzmann and Scherf in 1932 [1]. Until 1932 the
presence of a broad QRS complex associated with paroxysmal
tachycardia was categorized as a bundle-branch block phe-
nomenon [2,3]. First histological evidence of accessory
pathway was proved in 1942 by Wood et al. [4]. David Scherf
Fig. 2 – ECG after electrical cardioversion. Sinus rhythm and pre-excitation (negative delta wave in III, aVF, positive delta wave
in V2–V6), two atrial premature beats (second and fourth beat) with marked pre-excitation.
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understanding of the pathogenesis of the Wolff–Parkinson–
White (WPW) syndrome in terms of a re-entrant circuit
involving both the AV node – His axis and the accessory
pathway. This hypothesis was not universally accepted
until the 1970s when Durrer and others applied invasive
electrical stimulation to the heart to conﬁrm the patho-
physiological processes [5–9]. Morady and Scheinman were
the ﬁrst to successfully ablate an accessory pathway
(posteroseptal) using high-energy direct-current shocks.
Subsequently Jackman, Kuck, Morady, and a number of
groups proved the remarkable safety and efﬁciency of
catheter ablation for pathways in all locations using radio
frequency energy [10].
Accessory atrioventricular pathways arise during embry-
onic evolution when atria and ventricles are not adequately
divided. These may be either isolated or multifocal with septal
or posterior location [11]. The electrical impulse can pass
through the pathway either antegrade, towards to ventricle,
retrograde, away from the ventricle or in both directions. The
majority of pathways allow conduction in both direction, with
retrograde only conduction occurring in 17–37% of cases
(known as a concealed accessory pathway) and antegrade only
conduction rarely seen [12,13]. The electrical activation of the
myocardium starts from sinoatrial node and reaches the
ventricles through both the accessory pathway and atrioven-
tricular (AV) node. As the accessory pathway conducts the
impulse faster than the AV node, the ventricular depolarisa-
tion starts from the accessory pathway region and is followed
by depolarisation via the AV node-His conduction system. This
results in a short PR interval and slurred upstroke of the QRS
complex known as the delta wave.The patients with pre-excitation ECG pattern are often
asymptomatic. The antegrade conductivity can spontaneously
resolve in about 30% of all cases. Symptomatic patients may
experience palpitations, dizziness, shortness of breath or
syncope. Of note the ﬁrst presentation of pre-excitation may
be a sudden cardiac death. Fortunately this happens very
rarely (0.15–0.4%) [14,15].
Symptoms are caused by atrioventricular re-entry tachy-
cardia (AVRT) which can be either orthodromic or antidromic.
The terminology depends on the direction of the electrical
impulse going through AV node. The ventricular myocardium
is activated through either the normal conduction system
resulting in a narrow complex tachycardia (orthodromic
AVRT) or through the accessory pathway (antidromic AVRT)
with a broad complex tachycardia.
A complex of symptoms due to supraventricular tachycar-
dia with evidence of pre-excitation on ECG is called WPW
syndrome [16]. The presence of an accessory pathways is
dangerous in patients with atrial ﬁbrillation [17–19]. The AV
node provides protection against a fast ventricular response to
atrial tachycardia. In the presence of a rapidly conducting
accessory pathway fast atrial electrical impulses conducted
via the pathway may lead to an extremely rapid ventricular
response with degeneration to ventricular ﬁbrillation.
The ﬁrst line of treatment for symptomatic patients is radio
frequency ablation of the accessory pathway with success rate
of 90–95% depending of its location [20–22]. There is no clear
indication for this treatment in asymptomatic patients but it
should be considered with respect to the patient's profession
(e.g. pilot), age (higher prevalence of atrial ﬁbrillation with
increasing age) and electrophysiological parameters of acces-
sory pathways. Medical management includes either class I
Fig. 3 – Catheter ablation of accessory pathway.
Start of the radio frequency energy application during atrial stimulation with marked pre-excitation (first three beats,
positive delta waves in aVL, V1, V4, V5, negative delta waves in II, III, aVF). Fourth and fifth stimulus is not conducted via
accessory pathway (successful ablation), fifth stimulus is conducted to ventricle via AV node with no marks of pre-excitation
– note narrow QRS complex, His bundle potential on HBE 2-3 (in first three beats hidden in pre-excited ventricular potential),
prolongation of atrioventricular interval on coronary sinus electrograms.
II, III, aVL, aVF, V1, V4, V5 – surface lead ECG, HRA – high right atrium, HBE 2-3 – electrogram from His bundle region, CS 9-10
– coronary sinus ostium electrogram, CS 1-2 – distal coronary sinus electrogram, RF bip – electrogram from ablation catheter.
Paper speed was 100 mm/s.
c o r e t v a s a 5 6 ( 2 0 1 4 ) e 4 2 7 – e 4 3 2e430antiarrhythmic drugs (propafenone) or class III (sotalol,
amiodarone) which slow down pathway conduction. The
use of AV node conduction blocking/slowing drugs (particu-
larly verapamil) may be harmful allowing rapid unopposed
conduction down the accessory pathway with the potential of
the above-mentioned consequences [23–25].
Summary
A careful ECG analysis is vital for obtaining a correct diagnosis
of pre-excited atrial ﬁbrillation. This is necessary for further
management with respect to the symptoms and prognosis,
particularly the risk of sudden cardiac death. The wider
differential diagnosis like ventricular tachycardia caused by
acute coronary syndrome based on history, ECG and laboratory
results could have been considered in brainstorming process,
but eliminated as a false route.
We also aimed to show a less common ECG presentation of
an accessory atrioventricular pathway due to negative deltawave in inferior leads. This could be potentially misleading for
less experienced physician who could be lead to believe that
they were dealing with consequences chest pain/acute
myocardial ischaemia – ventricular tachycardia and treat
the patient accordingly with potentially harmful medication.
We have to keep pre-excitation syndrome in mind
especially in young patients with history of palpitations but
it may occur at any age, irrespective of the presence of
comorbidities or risk factors.
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Fig. 4 – ECG after catheter ablation. Sinus rhythm with no signs of pre-excitation.
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